Carla Renata Arciola Present position: Full Professor of Clinical Pathology. Director of the Research Laboratory on Pathology of
Implant Infections at the Rizzoli Orthopaedic Institute in Bologna.
Director of the Research Laboratory on Immunorheumatology and Tissue rigeneration at the Rizzoli Orthopaedic Institute in Bologna.
Studies: Studies in the Classic Licei L. Costa of La Spezia,
G. Parini of Milan and Arnaldo of Brescia. Degree in Medicine and
Surgery cum laude, University of Milan and Naples.
Specialization in Ophthalmology, cum laude ,
University of Modena and Bologna. Degree in Bioengineering, cum
laude , University of Bologna. Specialization in Clinical
Pathology for Laboratory Management, University of Modena. PhD in
Experimental Pathology, University of Bologna.
Previous
professional positions: Merck Sharp & Dohme Award for
young researchers for the experimental study "Testing
biocompatibility of implant materials by cell cultures from ocular
tissues". From 1986 to 1989 she was Medical Researcher in the
Laboratory on the Biocompatibility of Implant Materials of the
Rizzoli Orthopaedic Institute. From 1989 to 2005 she was
Assistant-Director, vice-Director and Director of the
Rizzoli Research Laboratory on Biocompatibility of Implant
Materials. Since 2000 she is the Head of the Research Unit on
Implant Infections of the Rizzoli National Orthopaedic Institute.
On 2000 she gained the title of Associate Professor at the
University of Parma, Faculty of Medicine. Since 2002 she was Associate Professor of General Pathology, at the Faculty of
Medicine of the University of Bologna. She is Full Professor of
Clinical Pathology and of Pathology and Physiopathology for medical students, member of the
Academic Board of the PhD Course on Experimental Pathology of the
University of Bologna and Professor of General Pathology in the
post-graduate Specialization Schools on Physical Medicine and
Rehabilitation and on Dermatology at the Medical Faculty of the
University of Bologna.
She was National Coordinator of Research
Projects funded by the Health Ministry: (i) National Coordinator of
the Research Project Molecular interactions between opportunistic
bacteria and biomaterials in the pathogenesis of periprosthetic
infections (1999-2001), for which project she coordinated Four
Research Units from IRCCS, Universities and Istituto Superiore di
Sanità; (ii) National Coordinator of the Research Project
Pathogenesis and molecular epidemiology of implant infections and
prevention strategies (2002-2005), for which project she
coordinated Ten Research Units from IRCCS and Universities; (iii)
National Coordinator of the Research Project Opportunistic bacteria
responsible for orthopaedic implant-related infections. New
strategies for gene and molecular therapy (2006-2010), for which
project she coordinated Seven Research Units from IRCCS,
Universities and Istituto Superiore di Sanità. EU funding programmes, Project 725827 POR-FESR 2014-2020: “New nanostructured antibacterial films for applications in the biomedical field”. Co-PI of the Project (with PI the Scientific Director of IOR). Project 725827 POR-FESR 2014-2020, Research Unit “Evaluation of bacterial adhesion on new nanostructured films”. PI of the Research Unit.
She was Associate Editor of Biomaterials and Guest Editor of the Special Issue “Focus on Implant
Infections” of the Int J Artif Organs and of the Special Issue "Anti-infective Materials in Medicine and Technology" of Materials.
Referee of more than forty
international Journals quoted in Journal Citation Reports .
Member
of international scientific evaluation boards: “France's National
Research Agency”, “Swiss National Science Foundation”, “Research
Grants Council, Hong Kong, China”, “French Research Funding Agency,
action: "Laboratories of Excellence" (Labex)”,“Framework Programme
of the European Community”.
Research Lines: Pathology of implant
associated infection; Biocompatibility of implant materials; Implant pathology and tissue engineering; Molecular pathology of
orthopedic diseases. She is Author of 270 printed publications,
including book chapters and 170 journal publications quoted in ISI,
PubMed, ToxLine.
